Celldex Therapeutics (CLDX)
2.58
+0.04 +1.57%
NASDAQ
Jun 22, 20:00
Delayed 2m
USD
View All Key Stats
CLDX Key Stats
| Income Statement | |
| Revenue (TTM) | 7.016M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.19 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -128.12M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -2.23K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 323.40M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 39.61 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 1.305 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | -- |
| Free Cash Flow (Quarterly) | -35.64M |
| Return on Equity (TTM) | -52.29% |
View All CLDX News
CLDX News
-
WireHeadlineTime (ET)
-
Yahoo06/18 14:32
-
SA Breaking News06/16 09:11
-
MT Newswires06/16 08:19
-
Globe Newswire06/16 08:01
-
Yahoo06/13 07:17
-
Yahoo06/12 08:42
-
Yahoo06/11 09:47
-
Yahoo06/07 08:00
-
Yahoo06/06 16:53
-
Globe Newswire06/06 16:01
View All Events
CLDX Events
| Date | Type | Description |
|---|---|---|
| 05/09/2017 | Earnings | Celldex Therapeutics Inc First Quarter Earnings Results in 2017 |
| 03/14/2017 16:30 EST | Misc | Celldex Therapeutics Inc Fourth Quarter Earnings Conference Call in 2016 |
| 03/14/2017 | Earnings | Celldex Therapeutics Inc Fourth Quarter Earnings in 2016 Release |
| 11/29/2016 | Misc | Celldex Therapeutics Completes Acquisition of Kolltan Pharmaceuticals |
| 11/07/2016 | Earnings | Celldex Therapeutics Inc Third Quarter Earnings Results in 2016 |
| 11/01/2016 | Misc | Celldex Expands Antibody and Immuno-oncology Portfolio With the Acquisition of Kolltan Pharmaceuticals |
| 08/08/2016 16:30 EDT | Misc | Celldex Therapeutics Inc Second Quarter Earnings Conference Call in 2016 |
| 08/08/2016 | Earnings | Celldex Therapeutics Inc Second Quarter Earnings in 2016 Release |
CLDX Fundamentals
Income Statement View Statement
CLDX Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
CLDX One Page Reports
- One Page Report Download
CLDX Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 2.58 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.celldex.com
- Investor Relations URL: http://ir.celldex.com/index.cfm
- HQ State/Province: New Jersey
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: May. 09, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Celldex Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the development and commercialization of immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases.
CLDX Comparables
EditCLDX Excel Add-In Codes
- Name: =YCI("CLDX","name")
- Description: =YCI("CLDX","description")
- Sector: =YCI("CLDX","sector")
- Industry: =YCI("CLDX","industry")
- Est. Current Fiscal Year End: =YCI("CLDX","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other CLDX Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- CLDX Tweets Stocktwits
Advertisement
